AMGN vs MAC · P/E 24, rev $36.75B vs rev $918.2M
Amgen Inc (AMGN) versus Macerich Company (MAC) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Macerich Company (MAC) is a reit - retail company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. MAC currently screens at market cap $4.41B.
Not investment advice. Open the AMGN and MAC stock pages for the full models.
Not investment advice.